Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cone

Showing results (191-200 of 368) with videos related to

Pageof 37
Sort By:
Journal of Analytical Toxicology|October 24, 2000
The disposition of cocaine and opiate analytes in hair and fingernails of humans following cocaine and codeine administrationJ D Ropero-Miller, B A Goldberger, E J Cone, et al.
Transplantation|December 1, 1976
Transplantation in miniature swine. I. Fixation of the major histocompatibility complexD H Sachs, G Leight, J Cone, et al.
Journal of Analytical Toxicology|November 2, 2004
Passive cannabis smoke exposure and oral fluid testingSam Niedbala, Keith Kardos, Sal Salamone, et al.
Journal of Analytical Toxicology|February 21, 2018
Bioavailability and Pharmacokinetics of Oral Cocaine in HumansMarion A Coe, Rebecca A Jufer Phipps, Edward J Cone, et al.
Current Biology : CB|April 19, 2024
Stimulus-dependent differences in cortical versus subcortical contributions to visual detection in miceJackson J Cone, Autumn O Mitchell, Rachel K Parker, et al.
Eneuro|March 15, 2019
Different Inhibitory Interneuron Cell Classes Make Distinct Contributions to Visual Contrast PerceptionJackson J Cone, Megan D Scantlen, Mark H Histed, et al.
Journal of Analytical Toxicology|November 15, 2008
Urine drug testing of chronic pain patients: licit and illicit drug patternsEdward J Cone, Yale H Caplan, David L Black, et al.
Journal of Analytical Toxicology|October 1, 1996
Cocaine disposition in meconium from newborns of cocaine-abusing mothers and urine of adult drug usersJ Oyler, W D Darwin, K L Preston, et al.
Journal of Opioid Management|January 9, 2018
Laboratory-based testing to evaluate abuse-deterrent formulations and satisfy the Food and Drug Administration's recommendation for Category 1 TestingChristopher Altomare, Eric R Kinzler, August R Buchhalter, et al.
Journal of Analytical Toxicology|November 30, 2006
Caffeine content of decaffeinated coffeeRachel R McCusker, Brian Fuehrlein, Bruce A Goldberger, et al.
Pageof 37

Showing results (191-200 of 368) with videos related to

Sort By:
Pageof 37
Journal of Analytical Toxicology|October 24, 2000
The disposition of cocaine and opiate analytes in hair and fingernails of humans following cocaine and codeine administrationJ D Ropero-Miller, B A Goldberger, E J Cone, et al.
Transplantation|December 1, 1976
Transplantation in miniature swine. I. Fixation of the major histocompatibility complexD H Sachs, G Leight, J Cone, et al.
Journal of Analytical Toxicology|November 2, 2004
Passive cannabis smoke exposure and oral fluid testingSam Niedbala, Keith Kardos, Sal Salamone, et al.
Journal of Analytical Toxicology|February 21, 2018
Bioavailability and Pharmacokinetics of Oral Cocaine in HumansMarion A Coe, Rebecca A Jufer Phipps, Edward J Cone, et al.
Current Biology : CB|April 19, 2024
Stimulus-dependent differences in cortical versus subcortical contributions to visual detection in miceJackson J Cone, Autumn O Mitchell, Rachel K Parker, et al.
Eneuro|March 15, 2019
Different Inhibitory Interneuron Cell Classes Make Distinct Contributions to Visual Contrast PerceptionJackson J Cone, Megan D Scantlen, Mark H Histed, et al.
Journal of Analytical Toxicology|November 15, 2008
Urine drug testing of chronic pain patients: licit and illicit drug patternsEdward J Cone, Yale H Caplan, David L Black, et al.
Journal of Analytical Toxicology|October 1, 1996
Cocaine disposition in meconium from newborns of cocaine-abusing mothers and urine of adult drug usersJ Oyler, W D Darwin, K L Preston, et al.
Journal of Opioid Management|January 9, 2018
Laboratory-based testing to evaluate abuse-deterrent formulations and satisfy the Food and Drug Administration's recommendation for Category 1 TestingChristopher Altomare, Eric R Kinzler, August R Buchhalter, et al.
Journal of Analytical Toxicology|November 30, 2006
Caffeine content of decaffeinated coffeeRachel R McCusker, Brian Fuehrlein, Bruce A Goldberger, et al.
Pageof 37